Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and redox-active cellular components represent a diverse group of oxygen-derived molecules, including free radicals like superoxide (O2•−) and non-radicals like hydrogen peroxide (H2O2), which are essential for cellular homeostasis [1]. These species are primarily generated as byproducts of mitochondrial oxidative phosphorylation and by specialized enzymes such as NADPH oxidases [2]. At physiological concentrations, ROS function as critical signaling molecules in processes like cell proliferation, differentiation, and the innate immune response [1][3]. However, an imbalance between ROS production and the capacity of antioxidant systems (e.g., glutathione, superoxide dismutase) leads to oxidative stress, causing cumulative damage to DNA, proteins, and lipids [3]. This oxidative damage is a central driver in the pathogenesis of cancer, neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS), and cardiovascular disorders [2][4]. Therapeutic interventions, such as the drug edaravone, target these species by acting as free radical scavengers to mitigate tissue damage [5]. Despite their therapeutic potential, the non-specific nature of ROS and their requirement for normal signaling pose significant challenges, as excessive suppression can disrupt vital physiological functions [1][3].
Direct scavenging of free radicals, neutralization of reactive oxygen species, and enhancement of endogenous antioxidant defense systems.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and redox-active cellular components (ROS).